Menu

Crypto Daily: Bitcoin interest in the doldrums – Proactive Investors USA

all41author 1 year ago 0 0

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which sections of the website you find most interesting and useful. See our Cookie Policy for more information.
Strictly Necessary and Functional
These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.
Advertising
Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.
Performance
Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.
Pharma & Biotech
Sustainability
Cannabis
Battery Metals
Psychedelics
Pharma & Biotech
Sustainability
Cannabis
Battery Metals
Psychedelics
William kickstarted his career as a researcher and reporter for a global legal publication, covering everything from public law to M&A. Before moving to Proactive Investors, he worked as a reporter for a major fintech company with a focus on cryptocurrency and blockchain technology. Harking from Queensland, Australia, William obtained first-class honours in journalism and media from Birkbeck University before going on to complete an MA in creative and critical writing. Other jobs have… Read more
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.
Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.
We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.
The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.
Proactive has always been a forward looking and enthusiastic technology adopter.
Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.
Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.
RocketFuel is revolutionizing online payments with cryptocurrencies and seamless checkout experience
Published: 03:52 15 Aug 2023

There is little to be surprised about on the crypto markets this morning.
Bitcoin remains trapped in a sideways trading channel, having closed Monday’s session at US$29,400.
This marks the 21st day that the BTC/USDT pair has closed between the 29k to 30k range, indicating a true lack of momentum on either side of the buy-sell market.
Price action on the world’s largest cryptocurrency remained subdued in this morning’s Asia trading session, dipping 0.2% to US$29,370.
Most metrics point to a sustained lack of excitement in the bitcoin markets.
Barring brief spikes, exchange-traded volumes have been on a consistent downward trend over the past six months, while low volatility has seen little price discovery opportunity on the futures market.
Indicative of the malaise in the market, the Crypto Fear & Greed Index, which tracks bitcoin volumes, volatility and dominance, has been stuck in the neutral zone since mid-July.
As has been the running theme for months, bitcoin bulls are salivating over the prospect of spot bitcoin exchange-traded funds (ETFs) bagging approval from the US Securities and Exchange Commission (SEC).
US brokerage firm Sanford C. Bernstein just released a research paper suggesting that ETFs could account for as much as 10% of bitcoin’s market value within three years if the securities watchdog gives them the regulatory nod.
That, however, is a big if.
For a while, optimism seemed to be growing around the prospect of a slot bitcoin ETF, through former SEC attorney John Reed Stark recently threw cold water on that optimism “for a range of compelling reasons”.
For now, bitcoin remains rangebound with support lined up around US$28,900 mark, per Binance’s order book.
Bitcoin price chart
Bitcoin at home on the rangebound – Source: currency.com
The second-largest cryptocurrency Ethereum (ETH) remains firmly planted in its own sideways channel between US$1,800 and US$1,900.
The ETH/USD pair closed Monday 0.3% higher at US$1,845, where it has remained this morning.
Solana (SOL) and Shiba Inu (SHIB) are the best performers among the top-20 altcoins, adding 7% and 13% week on week respectively.
Meanwhile, Binance’s BNB token, Cardano (ADA) and Litecoin (LTC) have sustained low-single-digit losses over the past week.
Global cryptocurrency market capitalisation currently stands at US$1.17 trillion, with bitcoin dominance sitting strong at 49.74%.
Add related topics to MyProactive
ProactiveInvestors is a publisher. You understand and agree that no content in this record or published on ProactiveInvestors’ website (the “Site”) constitutes a…
Sign up to receive alerts and news direct to your inbox
Tiziana Life Sciences Ltd (NASDAQ:TLSA) chief medical officer and chief operating officer Matthew Davis speaks to Thomas Warner from Proactive after announcing that Tiziana has received FDA clearance to investigate Foralumab as a potential treatment for Alzheimer's disease. Davis says that…
Prev article
Next article
Only registered members can use this feature.
or
Copyright © Proactive Group Holdings Inc, 2023
All Rights Reserved – Proactive North America Inc., Proactive Investors LLC.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.

source

– Advertisement –
Written By

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *